UCP1 and obesity disorder: Strategies targeting brown adipose tissue growth and UCP1 activation, such as pharmacological triggering of β3-adrenergic receptors in adipocytes, offer therapeutic approaches to combat diabetes, obesity, and related diseases, even in the absence of natural stimuli [9,10].